HBIO
Price
$0.50
Change
-$0.02 (-3.85%)
Updated
Aug 29, 03:56 PM (EDT)
Capitalization
23.17M
69 days until earnings call
IRMD
Price
$72.44
Change
-$0.59 (-0.81%)
Updated
Aug 29, 02:18 PM (EDT)
Capitalization
928.81M
63 days until earnings call
Interact to see
Advertisement

HBIO vs IRMD

Header iconHBIO vs IRMD Comparison
Open Charts HBIO vs IRMDBanner chart's image
Harvard Bioscience
Price$0.50
Change-$0.02 (-3.85%)
Volume$100
Capitalization23.17M
iRadimed
Price$72.44
Change-$0.59 (-0.81%)
Volume$422
Capitalization928.81M
HBIO vs IRMD Comparison Chart in %
Loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HBIO vs. IRMD commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIO is a Hold and IRMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (HBIO: $0.52 vs. IRMD: $73.02)
Brand notoriety: HBIO and IRMD are both not notable
HBIO represents the Pharmaceuticals: Other, while IRMD is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: HBIO: 39% vs. IRMD: 68%
Market capitalization -- HBIO: $23.17M vs. IRMD: $928.81M
HBIO [@Pharmaceuticals: Other] is valued at $23.17M. IRMD’s [@Medical/Nursing Services] market capitalization is $928.81M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HBIO’s FA Score shows that 0 FA rating(s) are green whileIRMD’s FA Score has 1 green FA rating(s).

  • HBIO’s FA Score: 0 green, 5 red.
  • IRMD’s FA Score: 1 green, 4 red.
According to our system of comparison, IRMD is a better buy in the long-term than HBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HBIO’s TA Score shows that 5 TA indicator(s) are bullish while IRMD’s TA Score has 5 bullish TA indicator(s).

  • HBIO’s TA Score: 5 bullish, 4 bearish.
  • IRMD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HBIO is a better buy in the short-term than IRMD.

Price Growth

HBIO (@Pharmaceuticals: Other) experienced а +9.26% price change this week, while IRMD (@Medical/Nursing Services) price change was +3.53% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.54%. For the same industry, the average monthly price growth was +5.85%, and the average quarterly price growth was +15.08%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.48%. For the same industry, the average monthly price growth was +6.46%, and the average quarterly price growth was +9.89%.

Reported Earning Dates

HBIO is expected to report earnings on Nov 06, 2025.

IRMD is expected to report earnings on Oct 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.54% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+0.48% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRMD($929M) has a higher market cap than HBIO($23.2M). IRMD YTD gains are higher at: 33.908 vs. HBIO (-75.346). IRMD has higher annual earnings (EBITDA): 24.6M vs. HBIO (-46.8M). IRMD has less debt than HBIO: IRMD (59.2K) vs HBIO (43.3M). HBIO has higher revenues than IRMD: HBIO (88.8M) vs IRMD (77.6M).
HBIOIRMDHBIO / IRMD
Capitalization23.2M929M2%
EBITDA-46.8M24.6M-190%
Gain YTD-75.34633.908-222%
P/E RatioN/A45.87-
Revenue88.8M77.6M114%
Total Cash7.44MN/A-
Total Debt43.3M59.2K73,142%
FUNDAMENTALS RATINGS
HBIO vs IRMD: Fundamental Ratings
HBIO
IRMD
OUTLOOK RATING
1..100
1476
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
10020
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6538
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRMD's Valuation (60) in the Medical Specialties industry is somewhat better than the same rating for HBIO (100) in the Biotechnology industry. This means that IRMD’s stock grew somewhat faster than HBIO’s over the last 12 months.

IRMD's Profit vs Risk Rating (20) in the Medical Specialties industry is significantly better than the same rating for HBIO (100) in the Biotechnology industry. This means that IRMD’s stock grew significantly faster than HBIO’s over the last 12 months.

IRMD's SMR Rating (100) in the Medical Specialties industry is in the same range as HBIO (100) in the Biotechnology industry. This means that IRMD’s stock grew similarly to HBIO’s over the last 12 months.

IRMD's Price Growth Rating (38) in the Medical Specialties industry is in the same range as HBIO (65) in the Biotechnology industry. This means that IRMD’s stock grew similarly to HBIO’s over the last 12 months.

IRMD's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as HBIO (100) in the Biotechnology industry. This means that IRMD’s stock grew similarly to HBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HBIOIRMD
RSI
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
61%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 3 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 10 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASPI10.530.45
+4.51%
ASP Isotopes
ZVIA2.70N/A
N/A
Zevia PBC
CTVA74.32-0.71
-0.95%
Corteva
SLAB137.45-2.22
-1.59%
Silicon Laboratories
GYRO10.25-0.42
-3.91%
Gyrodyne LLC

HBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HBIO has been loosely correlated with IRMD. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HBIO jumps, then IRMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HBIO
1D Price
Change %
HBIO100%
-2.60%
IRMD - HBIO
46%
Loosely correlated
-1.12%
A - HBIO
37%
Loosely correlated
+5.28%
RVTY - HBIO
36%
Loosely correlated
+0.72%
MTD - HBIO
35%
Loosely correlated
-0.17%
NEOG - HBIO
34%
Loosely correlated
+0.17%
More

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
-1.12%
HBIO - IRMD
45%
Loosely correlated
-2.60%
CERS - IRMD
43%
Loosely correlated
N/A
ZIMV - IRMD
43%
Loosely correlated
-0.37%
TWST - IRMD
41%
Loosely correlated
-2.21%
ITGR - IRMD
40%
Loosely correlated
-0.64%
More